Seekyo Therapeutics
Created in 2018
Up & running (A)
Existing signals show a regular activitySocial networks
1,204Activities
Technologies
Entity types
Location
2 Av. Galilée, 86360 Chasseneuil-du-Poitou, France
Chasseneuil-du-Poitou
France
Employees
Scale: 2-10
Estimated: 6
Engaged catalyst
1
0 0Added in Motherbase
8 months ago
Value proposition
Tumor Activated Therapy:
targeting Tumor Micro-Environment functional proteins to induce tumor self-destruction
The heterogeneity of cancer cells constitutes a strong limitation for the treatment of solid cancers like pancreas and Breast TNBC.
Shifting to a new paradigm, Seekyo, a pre-clinical biotech Co. overpowers this challenge by targeting specific functional proteins selectively produced within the Tumor Micro-Environment (TME).
Seekyo’s lead compound SKY01 induces a selective tumor self-destruction:
• Efficacy and safety validated in small and large animals (e.g. Dogs).
• Unprecedented antitumor efficacy vs. Standards of Care
• Efficient in several tumors (Pancreas, Triple Negative Breast Cancer, lung, colorectal...)
• Low Cost of Goods
Therapeutic vectors, ADC, Microenvironment, Cancer, Oncology, Therapeutic vector, Smart Molecular System, Drug Delivery System, in vitro, in vivo, Life Science, Biotechnology, Chemotherapy, Cancer treatment, Innovation, breaking through, breaking through technology, Molecular platform, Treatment side effects, Cancer side effects, Adverse effects, and Chemotherapy adverse effectsOriginal language
Tumor Activated Therapy:
targeting Tumor Micro-Environment functional proteins to induce tumor self-destruction
The heterogeneity of cancer cells constitutes a strong limitation for the treatment of solid cancers like pancreas and Breast TNBC.
Shifting to a new paradigm, Seekyo, a pre-clinical biotech Co. overpowers this challenge by targeting specific functional proteins selectively produced within the Tumor Micro-Environment (TME).
Seekyo’s lead compound SKY01 induces a selective tumor self-destruction:
• Efficacy and safety validated in small and large animals (e.g. Dogs).
• Unprecedented antitumor efficacy vs. Standards of Care
• Efficient in several tumors (Pancreas, Triple Negative Breast Cancer, lung, colorectal...)
• Low Cost of Goods
Seekyo | Tumor Activated Therapy
The next generation of targeted therapy for solid cancer
https://www.seekyo-therapeutics.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 25 Apr 2023 | | |